自身免疫性肝炎妊娠结局:基于人群的研究
该研究利用美国全国住院患者样本2012至2016年加权出院数据,评估孕20周后自身免疫性肝炎(AIH)与无慢性肝病(CLD)或其他CLD孕妇的母婴结局。AIH与妊娠期糖尿病、高血压并发症及早产风险升高相关,但未增加产后出血、孕产妇或围产期死亡。
要点
- AIH孕妇妊娠期糖尿病和高血压并发症风险显著高于其他CLD及无CLD孕妇。
- AIH与无CLD孕妇相比早产风险升高,但与产后出血及母婴死亡无显著关联。
- AIH妊娠率近年稳定,但需关注糖尿病、高血压及早产等母婴风险。
核心结论
- AIH孕妇妊娠率近年保持稳定,但妊娠期糖尿病、高血压并发症和早产风险显著增加,产后出血及母婴死亡风险低。
研究设计与样本
- 基于美国全国住院患者样本2012至2016年加权出院数据的回顾性人群研究,纳入孕20周后妊娠,比较AIH与其他CLD或无CLD孕妇的结局,采用逻辑回归分析关联。
- 共纳入18,595,345例妊娠,其中AIH 935例(含肝硬化60例),其他CLD 120,100例(含肝硬化845例)。
主要发现
- 与无CLD相比,AIH孕妇妊娠期糖尿病风险升高(OR 2.4,95%CI 1.6-3.6,p<0.001)。
- 与无CLD相比,AIH孕妇高血压并发症风险升高(OR 2.4,95%CI 1.3-4.1,p=0.003)。
- 与无CLD相比,AIH孕妇早产风险升高(OR 2.0,95%CI 1.2-3.5,p=0.01)。
- 与其他CLD相比,AIH孕妇妊娠期糖尿病风险升高(OR 2.2,95%CI 1.5-3.9,p<0.001)。
- 与其他CLD相比,AIH孕妇高血压并发症风险升高(OR 1.8,95%CI 1.0-3.2,p=0.05)。
关键数值与推荐
- AIH孕妇妊娠期糖尿病风险较无CLD升高(OR 2.4,95%CI 1.6-3.6,p<0.001)。
- AIH孕妇高血压并发症风险较无CLD升高(OR 2.4,95%CI 1.3-4.1,p=0.003)。
- AIH孕妇早产风险较无CLD升高(OR 2.0,95%CI 1.2-3.5,p=0.01)。
- AIH孕妇妊娠期糖尿病风险较其他CLD升高(OR 2.2,95%CI 1.5-3.9,p<0.001)。
- AIH孕妇高血压并发症风险较其他CLD升高(OR 1.8,95%CI 1.0-3.2,p=0.05)。
临床怎么用
- 对AIH孕妇应加强妊娠期糖尿病和高血压并发症的筛查与管理,并关注早产风险。
- AIH孕妇产后出血及母婴死亡风险低,可据此进行围产期咨询。
局限性
- 研究为回顾性数据库分析,无法评估糖皮质激素使用或AIH疾病活动度对结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Autoimmune hepatitis (AIH) disproportionately affects young women, which may have implications in pregnancy. However, data on pregnancy outcomes in women with AIH are limited. APPROACH AND RESULTS: Using weighted discharge data from the United States National Inpatient Sample from 2012 to 2016, we evaluated pregnancies after 20 weeks gestation and compared outcomes in AIH to other chronic liver diseases (CLD) or no CLD in pregnancy. The association of AIH with maternal and perinatal outcomes was assessed by logistic regression. Among 18,595,345 pregnancies, 935 (<0.001%) had AIH (60 with cirrhosis) and 120,100 (0.006%) had other CLD (845 with cirrhosis). Temporal trends in pregnancies with AIH remained stable from 2008 to 2016 with 1.4-6.8/100,000 pregnancies per year (p = 0.25). On adjusted analysis, the odds of gestational diabetes (GDM) and hypertensive complications (pre-eclampsia, eclampsia, or hemolysis, elevated liver enzymes, low platelets) were significantly higher in AIH compared to other CLD (GDM: OR 2.2, 95% CI: 1.5-3.9, p < 0.001; hypertensive complications: OR: 1.8, 95% CI: 1.0-3.2, p = 0.05) and also compared to no CLD in pregnancy (GDM: OR: 2.4, 95% CI: 1.6-3.6, p < 0.001; hypertensive complications: OR: 2.4, 95% CI: 1.3-4.1, p = 0.003). AIH was also associated with preterm births when compared with women without CLD (OR: 2.0, 95% CI: 1.2-3.5, p = 0.01). AIH was not associated with postpartum hemorrhage, maternal, or perinatal death. CONCLUSIONS: Rates of pregnancy in women with AIH have remained stable in recent years, although AIH is associated with notable maternal and perinatal risks, such as GDM, hypertensive complications, and preterm birth. Whether these risks are influenced by steroid use and/or AIH disease activity warrants evaluation. These data support a low risk of postpartum hemorrhage and favorable survival of mothers and infants.
引用
- Wang CW, Grab J, Tana MM, et al. Outcomes of pregnancy in autoimmune hepatitis: A population-based study. Hepatology. 2021. PMID: 34455632. doi:10.1002/hep.32132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。